Bausch + Lomb (BLCO) Reports Q3 2025 Earnings with Revenue Growth
Bausch + Lomb (BLCO) reported Q3 2025 earnings with total revenue of $1.281 billion, reflecting 6% year-over-year growth. The company saw strong performance in its vision care and pharmaceuticals segments, with notable growth in contact lenses, dry eye products, and Miebo. The results indicate a positive trend across multiple product lines.
Topics: Contact Lenses Earnings Pharmaceuticals Revenue Growth Surgical Segment Vision Care